Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jbm.a.37059 http://scihub22266oqcxt.onion/10.1002/jbm.a.37059 32662571!7405498!32662571     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Biomed+Mater+Res+A 2020 ; 108 (10): 1974-1990 Nephropedia Template TP {{tp|p=32662571|t=2020. Opportunities for biomaterials to address the challenges of COVID-19 |pdf=|usr=}}{{32662571}} gab.com Text Opportunities for biomaterials to address the challenges of COVID-19 JO: J Biomed Mater Res A http://www.kidney.de/pget.php?&tw=1&pmid=32662571 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic has revealed major shortcomings in our ability to mitigate transmission of infectious viral disease and provide treatment to patients, resulting in a public health crisis. Within months of the first reported case in China, the virus has spread worldwide at an unprecedented rate. COVID-19 illustrates that the biomaterials community was engaged in significant research efforts against bacteria and fungi with relatively little effort devoted to viruses. Accordingly, biomaterials scientists and engineers will have to participate in multidisciplinary antiviral research over the coming years. Although tissue engineering and regenerative medicine have historically dominated the field of biomaterials, current research holds promise for providing transformative solutions to viral outbreaks. To facilitate collaboration, it is imperative to establish a mutual language and adequate understanding between clinicians, industry partners, and research scientists. In this article, clinical perspectives are shared to clearly define emerging healthcare needs that can be met by biomaterials solutions. Strategies and opportunities for novel biomaterials intervention spanning diagnostics, treatment strategies, vaccines, and virus-deactivating surface coatings are discussed. Ultimately this review serves as a call for the biomaterials community to become a leading contributor to the prevention and management of the current and future viral outbreaks. Twit Text FOAVip Opportunities for biomaterials to address the challenges of COVID-19 ????J Biomed Mater Res A http://www.kidney.de/pget.php?&tw=1&pmid=32662571 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32662571 #FOAvip English Wikipedia <ref>{{Cite pmid|32662571}}</ref> Opportunities for biomaterials to address the challenges of COVID-19 #MMPMID32662571 Chakhalian D; Shultz RB; Miles CE; Kohn J J Biomed Mater Res A 2020[Oct]; 108 (10): 1974-1990 PMID32662571show ga The coronavirus disease 2019 (COVID-19) pandemic has revealed major shortcomings in our ability to mitigate transmission of infectious viral disease and provide treatment to patients, resulting in a public health crisis. Within months of the first reported case in China, the virus has spread worldwide at an unprecedented rate. COVID-19 illustrates that the biomaterials community was engaged in significant research efforts against bacteria and fungi with relatively little effort devoted to viruses. Accordingly, biomaterials scientists and engineers will have to participate in multidisciplinary antiviral research over the coming years. Although tissue engineering and regenerative medicine have historically dominated the field of biomaterials, current research holds promise for providing transformative solutions to viral outbreaks. To facilitate collaboration, it is imperative to establish a mutual language and adequate understanding between clinicians, industry partners, and research scientists. In this article, clinical perspectives are shared to clearly define emerging healthcare needs that can be met by biomaterials solutions. Strategies and opportunities for novel biomaterials intervention spanning diagnostics, treatment strategies, vaccines, and virus-deactivating surface coatings are discussed. Ultimately this review serves as a call for the biomaterials community to become a leading contributor to the prevention and management of the current and future viral outbreaks. |*Betacoronavirus/genetics/pathogenicity/physiology[MESH] |*Biocompatible Materials[MESH] |*Coronavirus Infections/diagnosis/drug therapy/epidemiology/prevention & control/therapy/transmission[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/diagnosis/prevention & control/therapy/transmission[MESH] |Biosensing Techniques[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Testing[MESH] |COVID-19 Vaccines[MESH] |Clinical Laboratory Techniques[MESH] |Disinfection/methods[MESH] |Drug Delivery Systems[MESH] |Extracorporeal Circulation[MESH] |Filtration[MESH] |Humans[MESH] |Immunologic Tests/instrumentation/methods[MESH] |Metals[MESH] |Nanostructures[MESH] |Nucleic Acid Amplification Techniques/instrumentation/methods[MESH] |Protective Devices[MESH] |RNA, Viral/analysis[MESH] |SARS-CoV-2[MESH] |Severe Acute Respiratory Syndrome/epidemiology/transmission[MESH] |Surface-Active Agents[MESH] |Tissue Engineering[MESH]Opportunities for biomaterials to address the challenges of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing